Orthopedic MedTech Firm Huake Run Raises Tens of Millions, Advances 'Robot + Consumables + Equipment' Platform

Smart Medical Device Network NewsRecently, Hicren Medtech, a developer of minimally invasive spinal surgical medical devices, announced the completion of a financing round worth tens of millions of yuan.Pre-C+This round of financing was exclusively funded by Chengshu Investment. It is reported that the funds will be mainly invested in the research and development and commercialization layout of orthopedic micro-robots and intelligent digital products, further strengthening its competitive advantage in the field of AI medical devices.

Data shows that Hicren (Ningbo) Medtech Co., Ltd. was established2011Year, located in the industrial new city at the geometric center adjacent to Shanghai, Hangzhou, and Ningbo — Hangzhou Bay New Area. Since its establishment, Hicren Medtech has gathered a group of professionals from around the world.500Strong, senior management talents from enterprises listed in China and abroad, as well as outstanding R&D personnel in medical devices. Through continuous innovation and integration, the company's team is committed to building Hicren Medtech into an innovative enterprise that is a robotic-enabled digital orthopedic minimally invasive platform.

Hicren Medtech is the first enterprise in China to obtain domestic and EU approval for its curved-angle vertebral augmentation products, and it is also the most comprehensive surgical instrument manufacturer in China offering both curved-angle and traditional vertebral augmentation solutions. As the global leader in curved-angle vertebral augmentation technology, it is the preferred provider of high-quality vertebral augmentation instruments for customers.

At the same time, the company owns a full range of vertebral body forming products, as well as innovative products in the fields of spinal implants, sports medicine, orthopedic active devices and consumables, artificial intelligence, etc. It has accumulated patent applications in China.203Items, including invention patents83Item, Utility Model109Item, Appearance Design11Items; Cumulative International Patent Applications10Item, International Patent Authorized8Item. Currently achieved17Zhang Erl12Zhang San ClassNMPAMedical Device Registration Certificate, ObtainedCECertification7Item, USA/FDACertification12Items, the expected number of certifications obtained annually in the future will be no less than5Item.

2021Year, Hicren Medtech Invests in European Innovative Robotics CompanyInterventional Systems（INS) Hundreds of millions of yuan in funding, and jointly established ZHONGOU Zhiwei (Shanghai) Robotics Co., Ltd. with it in Shanghai, becoming a landmark milestone for Hicren Medtech's entry into the digital orthopedics and surgical robotics market. Currently, ZHONGOU Zhiwei has cumulatively applied for domestic patents in China.18Item, Authorized Patent9Items, including inventions2Item, Utility Model2Item, Appearance Design5Item.

In addition, Hicren Medtech is a high-tech enterprise and has been repeatedly rated as a star enterprise in labor management. It has also been awarded titles such as Outstanding Enterprise in Zhejiang Province's Health Industry and Excellent Enterprise in the Ningbo Division of China's Innovation and Entrepreneurship Competition. In various innovation competitions, Hicren Medtech has won numerous awards.2017Awards such as the World Orthopedic Innovation Conference Best Innovative Orthopedic Device Award, the Second Prize in the Ningbo Division of China Innovation and Entrepreneurship Competition, and the Ningbo Hangzhou Bay New Area Enterprise Technology Innovation Team Award. Excellent management standards and outstanding innovation capabilities are the solid foundation and inexhaustible driving force for Hicren Medtech's rapid development and continuous progress.

To date, the company has focused on the orthopedics field and built a"Robot+Consumables+Equipment"At the Core"1+3+1"Comprehensive solutions, with product lines covering细分领域 such as vertebral body shaping kits, spinal implants, and bone repair materials.

From the perspective of the orthopedic surgical robot market, the current global orthopedic surgical robot market is mainly dominated by a few large enterprises, including Stryker (Stryker), Medtronic (Medtronic), Johnson & Johnson (Johnson&Johnson), etc. These companies have occupied the dominant position in the market through continuous technological innovation and product upgrades.

In China, companies such as Tinavi Medical Technologies and MicroPort Robotics are also making continuous efforts to increase their market share through technological innovation and market expansion.

In the Chinese market, the performance of the domestically produced brand Tianzhishu is particularly outstanding, with its development ofThe "Tianji" series orthopedic surgical robot is the world's first original product that achieves one-machine coverage of major orthopedic surgery types, including spinal surgery, orthopedic trauma surgery, and joint replacement surgery. The product reaches an internationally advanced level in terms of precision, efficiency, and ease of use, earning a good reputation for Chinese brands in the international market.

At the same time, the development of the orthopedic surgical robot market also faces significant challenges. For example, the high cost of orthopedic surgical robots and the substantial initial investment required limit the purchasing ability of some medical institutions, especially grassroots medical institutions.

In addition, the operation of orthopedic surgical robots requires specialized technical training for doctors and the surgical team. This increases the training costs and time investment for medical institutions and may also affect the smooth progress of surgeries.And as more and more companies enter the orthopedic surgical robot market, competition in the market will become increasingly fierce. How to maintain technological leadership and market advantage in the competition will be an important challenge for companies.

Overall, the orthopedic surgical robot market is in a stage of rapid development, driven by factors such as technological advancements and an aging population. However, challenges like high costs, technical training requirements, and regulatory restrictions still need to be addressed. In the future, with continuous technological innovation and further market segmentation, orthopedic surgical robots will become more intelligent, precise, and personalized. Additionally, global expansion and policy support will provide strong momentum for market growth.